Showing results (211-220 of 244) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerMichiel F G de Maat, Cornelis J H van de Velde, Naoyuki Umetani, et al.Cancers|May 25, 2024
Characterization of FOLH1 Expression in Renal Cell CarcinomaEric Ovruchesky, Elizabeth Pan, Melis Guer, et al.Cancer Cell|June 11, 2024
Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapyShannon N Geels, Alexander Moshensky, Rachel S Sousa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrenceMichiel F G de Maat, Cornelis J H van de Velde, Martijn P J van der Werff, et al.Nature Communications|July 15, 2022
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapyShijun Ma, Yue Zhao, Wee Chyan Lee, et al.Nature Communications|October 28, 2015
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelZhen Ning Wee, Siti Maryam J M Yatim, Vera K Kohlbauer, et al.Cancer Metastasis Reviews|June 14, 2006
Molecular mechanisms of metastasisDave S B Hoon, Minoru Kitago, Joseph Kim, et al.Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.Breast Cancer Research and Treatment|April 6, 2012
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort studyAnneke Q van Hoesel, Cornelis J H van de Velde, Peter J K Kuppen, et al.Cell Metabolism|November 26, 2019
STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor GrowthChunyan Zhang, Chanyu Yue, Andreas Herrmann, et al.Pageof 25